Navigation Links
Ovarian and Endometrial Cancer Patients Experience Improved Outcomes When Treated First by a Gynecologic Oncologist

CHICAGO, Sept. 24 /PRNewswire/ -- For the first time, accumulated data demonstrates that women diagnosed with a reproductive cancer, especially ovarian and uterine (endometrial) cancers, experience improved outcomes when treated first by a gynecologic oncologist. The 2008 State of the State of Gynecologic Cancers: Sixth Annual Report to the Women of America, published by the Gynecologic Cancer Foundation (GCF), details these results.

Gynecologic oncologists are physicians committed to the comprehensive treatment of women with cancer. After completing four years of medical school and four years of residency in obstetrics and gynecology, these physicians pursue an additional three to four years of training in gynecologic oncology through a rigorous fellowship program overseen by the American Board of Obstetrics and Gynecology. Gynecologic oncologists are not only trained to be skilled surgeons capable of performing wide-ranging cancer operations, but also are trained in prescribing the appropriate chemotherapy for those conditions and/or radiation therapy when indicated. Frequently, gynecologic oncologists are involved in research studies and clinical trials that are aimed at finding more effective and less toxic treatments to further advance the field and improve cure rates.

"While only approximately 1/3 of women with ovarian cancer receive their initial surgery for ovarian cancer from a gynecologic oncologist, those who do are more likely to experience the appropriate and recommended surgery," said Dr. Carol Brown, Medical Editor of the report and Associate Attending Surgeon, Memorial Sloan-Kettering Cancer Center. "Moreover, gynecologic oncologists are more likely to perform radical procedures during surgery resulting in a lower volume of residual disease. Data shows that patients operated on by surgeons more likely to use radical surgical procedures doubled their median survival time," she continued.

Endometrial cancer patients also have better outcomes when their initial surgery is performed by a gynecologic oncologist. This is true for two primary reasons: First, gynecologic oncologists are more likely to perform complete surgical staging that includes removal of lymph nodes from the pelvis and aortic regions. Second, when treating women with Stage I endometrial cancer, gynecologic oncologists are less likely to recommend follow-up radiation therapy. This reduces the cost of care by 31 percent, prevents complications from over-treatment and offers patients a better quality of life.

Similar benefits are experienced by patients diagnosed with other gynecologic cancers, primarily due to the extensive surgical skills of gynecologic oncologists.

The membership of the Society of Gynecologic Oncologist (SGO) is comprised primarily of gynecologic oncologists. "Our purpose as a profession is to help women achieve the best possible outcome from their gynecologic cancer diagnosis," stated Dr. Thomas Burke, SGO president. "It is our hope that the data in this report will help women and their healthcare providers make the appropriate decision regarding their care," he added.

"The American College of Obstetricians and Gynecologist (ACOG) recognizes that generalist obstetrician-gynecologists provide the majority of cancer screening and long-term follow up care for their patients," said Dr. Douglas Kirkpatrick, ACOG President. "This GCF/SGO report points out how collaboration with a gynecologic oncologist, where available, for cancer treatment and continuing care may provide additional benefit," Dr. Kirkpatrick stated.

To obtain a copy of the report or to learn more about gynecologic cancers, visit GCF's Women's Cancer Network(TM) at

The Gynecologic Cancer Foundation (GCF), founded by the Society of Gynecologic Oncologists in 1991, is a 501(c) 3 not-for-profit organization whose mission is to ensure public awareness of gynecologic cancer prevention, early diagnosis and proper treatment. In addition, the Foundation supports research and training related to gynecologic cancers. GCF advances this mission by increasing public and private funds that aid in the development and implementation of programs to meet these goals.

SOURCE Gynecologic Cancer Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. LOreal Paris Continues Passionate Commitment to Ovarian Cancer Research and Awareness Programs in 2008
2. National Ovarian Cancer Coalition and CSI: Miami Star Eva La Rue Launch Evas Divas in Hollywood to Educate Women Nationwide About Ovarian Cancer
3. New ovarian stimulation technique offers more cancer patients the chance to preserve their fertility
4. Ovarian cancers specific scent detected by dogs
5. Symptom Screening Plus a Simple Blood Test Equals a 20 Percent Jump in Early Detection of Ovarian Cancer
6. Symptoms Plus Blood Test Boost Ovarian Cancer Detection
7. Symptom screening plus a simple blood test improves early detection of ovarian cancer
8. PET/CT scan could be valuable noninvasive tool for determining stages of ovarian cancer
9. Ovarian function and fertility preserved in women with severe systemic lupus erythematosus
10. A Knock-Out Match: Kelly Ripa and Molly Sims Team Up to Fight Ovarian Cancer
11. Coveting the Latest Clutch? Bid on a Bag and Help Fight Ovarian Cancer
Post Your Comments:
(Date:11/28/2015)... ... November 28, 2015 , ... Pixel Film Studios is back ... to choose from, the possibilities are endless. Users have full control over angle of ... Pulse masking effects, users are sure to get heads to turn. , ProPanel: Pulse ...
(Date:11/27/2015)... ... , ... According to an article published November 15th by ABC ... security in light of the recent terrorist attacks in Paris, other cities are taking ... attack from reaching U.S. soil. Especially around special events that may be high-profile in ...
(Date:11/27/2015)... ... 27, 2015 , ... "When I was traveling, I was ... N.J. "Many people catch diseases simply from sitting on such dirty toilet seats. ... from germs." , He developed the patent-pending QUDRATECS to eliminate the need to ...
(Date:11/27/2015)... ... 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over ... More than 3.7 billion people under the age of 50 – or 67% of ... WHO's first global estimates of HSV-1 infection . , "The data shocks us highly!" ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... failing. Secura Consultants has prided itself for not only fulfilling the needs of ... protection solutions at an affordable price and providing top-tier customer service. However, there's ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015 ... the addition of the "Global Brain ... their offering. --> ) ... "Global Brain Monitoring Devices Market 2015-2019" ... Research and Markets ( ) has ...
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: ... License Application (BLA) with the United States ... ABP 501, a biosimilar candidate to Humira ® ... biosimilar application submitted to the FDA and represents Amgen,s ... Sean E. Harper , M.D., executive vice president ...
(Date:11/25/2015)... 2015  Linden Care, LLC, a retail specialty pharmacy ... patients suffering from chronic pain, said today that it ... Order (TRO) enjoining Express Scripts from unilaterally terminating the ... --> --> The company said ... options. --> --> ...
Breaking Medicine Technology: